The Effect of Vitamin D3 Supplemented with PhytoSolve on Genes Involved in Implantation in an NMRI Mice Model of Polycystic Ovary Syndrome: An Experimental Study

Overview

Journal JBRA Assist Reprod

Specialty Reproductive Medicine

Date 2023 Nov 14

PMID 37962973

Authors

Sahar Hakimpour

Azam Govahi

Sahar Eghbali

Ronak Shabani

Rana Mehdizadeh

Marziyeh Ajdary

Mehdi Mehdizadeh

Affiliations

Soon will be listed here.

Abstract

Objective: Vitamin D3 has been shown to be effective in the treatment of PCOS. However, due to its poor solvability and bioavailability, effective time is delayed and dosage requirements are increased. In our previous study, we demonstrated that PhytoSolve containing VD3 is more effective than vitamin D3 alone in the treatment of PCOS. In this study, we aimed to investigate the effect of this vitamin D3 formulation on gene expression involved in implantation in patients with PCOS.

Methods: To create PhytoSolve, Lipid S75, glycerol, and MCT oil were combined using a sonicator probe. Six groups, each consisting of 36 female Naval Medical Research Institute (NMRI) mice, were included in the following groups: control; sham; PCOS; PhytoSolve; PhytoSolve containing VD3; and vitamin D3. The mice were given DHEA injections to induce PCOS. After administering PhytoSolve containing VD3 and vitamin D3 by gavage for one week from the 13th day of model creation, the female mice were mated and endometrial tissue was collected for analysis of LIF, β-integrin, and HOXA10 proteins and genes.

Results: Compared to the group receiving vitamin D3 alone, the group receiving PhytoSolve containing vitamin D3 showed a significant increase in the expression of LIF, β-integrin, and HOXA10 genes (p<0.05). Although there was an increase in the expression of β-integrin and HOXA10 proteins in the group given PhytoSolve containing vitamin D3 compared to the group given vitamin D3, this increase was not significant. However, the increase in LIF protein expression in the group given PhytoSolve containing vitamin D3 was significant when compared to the group given vitamin D3 (p<0.05).

Conclusions: The use of PhytoSolve containing vitamin D3 was more effective than vitamin D3 alone. The PhytoSolve formulation might be a useful solution for medications with limited solubility and bioavailability.

References

Gatti D, Idolazzi L, Fassio A . Vitamin D: not just bone, but also immunity. Minerva Med. 2016; 107(6):452-460. View

Hahn S, Haselhorst U, Tan S, Quadbeck B, Schmidt M, Roesler S . Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes. 2006; 114(10):577-83. DOI: 10.1055/s-2006-948308. View

Apparao K, Lovely L, Gui Y, Lininger R, Lessey B . Elevated endometrial androgen receptor expression in women with polycystic ovarian syndrome. Biol Reprod. 2002; 66(2):297-304. DOI: 10.1095/biolreprod66.2.297. View

. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2003; 19(1):41-7. DOI: 10.1093/humrep/deh098. View

Bergeron C, Ferenczy A, Shyamala G . Distribution of estrogen receptors in various cell types of normal, hyperplastic, and neoplastic human endometrial tissues. Lab Invest. 1988; 58(3):338-45. View

Haddadzadegan S, Dorkoosh F, Bernkop-Schnurch A . Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev. 2022; 182:114097. DOI: 10.1016/j.addr.2021.114097. View

Ajdary M, Keyhanfar F, Aflatoonian R, Amani A, Amjadi F, Zandieh Z . Design and evaluation of a novel nanodrug delivery system for reducing the side effects of clomiphene citrate on endometrium. Daru. 2020; 28(2):423-432. PMC: 7704853. DOI: 10.1007/s40199-019-00310-2. View

Wajda R, Zirkel J, Schaffer T . Increase of bioavailability of coenzyme Q(10) and vitamin E. J Med Food. 2007; 10(4):731-4. DOI: 10.1089/jmf.2006.254. View

van Hoogevest P . Review - An update on the use of oral phospholipid excipients. Eur J Pharm Sci. 2017; 108:1-12. DOI: 10.1016/j.ejps.2017.07.008. View

10.

Trummer C, Pilz S, Schwetz V, Obermayer-Pietsch B, Lerchbaum E . Vitamin D, PCOS and androgens in men: a systematic review. Endocr Connect. 2018; 7(3):R95-R113. PMC: 5854850. DOI: 10.1530/EC-18-0009. View

11.

Donovan D, Papadopoulos A, Sarrel P, Bilezikian J . Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids. 1999; 64(6):430-5. DOI: 10.1016/s0039-128x(99)00012-4. View

12.

Kara M, Ozcan S, Aran T, Kara O, Yilmaz N . Evaluation of Endometrial Receptivity by Measuring HOXA-10, HOXA-11, and Leukemia Inhibitory Factor Expression in Patients with Polycystic Ovary Syndrome. Gynecol Minim Invasive Ther. 2019; 8(3):118-122. PMC: 6743234. DOI: 10.4103/GMIT.GMIT_112_18. View

13.

Cermik D, Selam B, Taylor H . Regulation of HOXA-10 expression by testosterone in vitro and in the endometrium of patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2003; 88(1):238-43. DOI: 10.1210/jc.2002-021072. View

14.

Jiang N, Li X . The Disorders of Endometrial Receptivity in PCOS and Its Mechanisms. Reprod Sci. 2021; 29(9):2465-2476. DOI: 10.1007/s43032-021-00629-9. View

15.

Amjadi F, Salehi E, Zandieh Z, Rashidi M, Taleahmad S, Masrour M . Comparative evaluation of NOTCH signaling molecules in the endometrium of women with various gynecological diseases during the window of implantation. Iran J Basic Med Sci. 2019; 22(4):426-431. PMC: 6535203. DOI: 10.22038/ijbms.2019.32961.7874. View

16.

Morgante G, Darino I, Spano A, Luisi S, Luddi A, Piomboni P . PCOS Physiopathology and Vitamin D Deficiency: Biological Insights and Perspectives for Treatment. J Clin Med. 2022; 11(15). PMC: 9369478. DOI: 10.3390/jcm11154509. View

17.

Qiao J, Wang L, Li R, Zhang X . Microarray evaluation of endometrial receptivity in Chinese women with polycystic ovary syndrome. Reprod Biomed Online. 2008; 17(3):425-35. DOI: 10.1016/s1472-6483(10)60228-3. View

18.

Fricker G, Kromp T, Wendel A, Blume A, Zirkel J, Rebmann H . Phospholipids and lipid-based formulations in oral drug delivery. Pharm Res. 2010; 27(8):1469-86. DOI: 10.1007/s11095-010-0130-x. View

19.

Wang S, Sun M, Ping Q . Enhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in rats. Int J Pharm. 2008; 358(1-2):198-204. DOI: 10.1016/j.ijpharm.2008.03.006. View

20.

Achache H, Revel A . Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update. 2006; 12(6):731-46. DOI: 10.1093/humupd/dml004. View